Study identifier:NIS-CDE-ATA-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Compliance of patients with essential hypertension treated with Candesartan or Candesartan/Hydrochlorothiazide - CoCa
hypertension
N/A
-
-
-
-
Observational
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|